The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

The U.K. biopharmaceutical company said data from a Phase 2 study of eRapa, a treatment for familial adenomatous polyposis, showed the drug to be safe and well-tolerated among users. The treatment ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Screening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...

Medicare Part D sometimes covers chemotherapy if someone takes the medications orally. It also covers other cancer drugs. Medicare Part B usually covers 80% of outpatient cancer-related services ...